Opportunity

Simpler Grants.gov #PAR-26-069

NINDS Forecasted Grant for Exploratory and Efficacy Clinical Trials

Buyer

National Institute of Neurological Disorders and Stroke (NINDS)

Posted

August 28, 2025

Respond By

February 10, 2026

Identifier

PAR-26-069

NAICS

541715

This opportunity is a forecasted research grant from the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (NIH): - Government Buyer: - National Institutes of Health (NIH) - National Institute of Neurological Disorders and Stroke (NINDS) - Purpose and Scope: - Funding for exploratory and efficacy clinical trials - Supports research on drugs, biologics, devices, surgical, behavioral, and rehabilitation therapies relevant to neurological disorders - Products/Services Requested: - No specific products, part numbers, or quantities are listed - Focus is on supporting clinical research projects, not procurement of goods - Eligibility and Requirements: - Open to educational institutions, government entities, businesses, nonprofits, tribal organizations, and foreign institutions - No cost sharing or matching required - Funding instrument: Cooperative agreement (UG3/UH3 activity code) - Notable Details: - No OEMs or vendors are specified, as this is a grant for research rather than a product or service acquisition - Opportunity is intended to advance therapies within the NINDS mission

Description

The National Institute of Neurological Disorders and Stroke (NINDS) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on exploratory and efficacy clinical trials. These trials may evaluate drugs, biologics, devices, surgical, behavioral, and rehabilitation therapies within the mission and research interests of NINDS. Applications are not being solicited at this time; this is a forecast to allow potential applicants time to prepare. The NOFO will utilize the UG3/UH3 activity code and is open to a wide range of eligible applicants, including educational institutions, government entities, businesses, and nonprofits.

View original listing